Are We Overtreating Patients With T1a HER2+ Breast Cancer? An Analysis of the National Cancer Database
{{output}}
Introduction: The potential benefit of systemic therapy in patients with T1a HER2+ cancers is not well understood, and no consensus guidelines exist. We sought to investigate practice patterns of chemotherapy use in this populati... ...
